Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/9458
Full metadata record
DC FieldValueLanguage
dc.contributor.authorHuang, Chong-Wei-
dc.contributor.authorLin, Jainn-Jim-
dc.contributor.authorKuo, Chen-Yen-
dc.contributor.authorLin, Kuang-Lin-
dc.contributor.authorHuang, Yhu-Chering-
dc.contributor.authorChiu, Cheng-Hsun-
dc.date.accessioned2024-12-20T07:12:36Z-
dc.date.available2024-12-20T07:12:36Z-
dc.date.issued2023-12-
dc.identifier.citationOriginal Articleen_US
dc.identifier.urihttp://localhost:8080/xmlui/handle/123456789/9458-
dc.description.abstractAbstract Background: Outbreak of Omicron BA.2 in Taiwan led to an increased number of acute encephalitis/encephalopathy cases in children and several fatal cases drew public attention. In pre-Omicron period, pediatric cases of COVID-19-associated acute encephalitis have been reported and during Omicron epidemic, febrile convulsions, encephalitis were mentioned more frequently. The outcome of patients with neurological complications was worse. However, few studies investigated the risk factors, pathophysiology and prognosis of COVID-19- associated encephalitis/encephalopathy. Here, we describe the presentation of pediatric cases of COVID-19-associated acute encephalitis/encephalopathy and explore the associated risk factors. Methods: Pediatric patients with confirmed SARS-CoV-2 infections were prospectively enrolled at admission at Chang Gung Memorial Hospital between April and August 2022. Patients were categorized into groups of acute encephalitis/encephalopathy, febrile convulsions or mild disease. Demographic descriptions, clinical manifestations and laboratory data were collected. Results: Of 288 acute COVID-19 patients, there were 38 (13.2%) acute encephalitis/encephalopathy, 40 (13.9%) febrile convulsions, and 210 (72.9%) mild disease. Among acute encephalitis/encephalopathy group, the mean age was 68.3 45.0 months. The common neurological symptoms were lethargy (65.8%), seizures (52.6%), and impaired consciousness (34.2%). Over 3 years old (adjusted odds ratio [aOR]: 7.57, p < 0.001), absolute neutrophil count 3150/ mL (aOR: 5.46, p Z 0.008), and procalcitonin 0.5 ng/mL (aOR: 4.32, p Z 0.021) were independent factors for acute encephalitis/encephalopathy. Conclusions: Most cases of COVID-19-associated acute encephalitis/encephalopathy showed no evidence of direct viral invasion but associations with older age, increased peripheral neutrophil, and serum procalcitonin. These findings may imply the neutrophil-mediated systemic inflammatory response plays an important role on central nerve system, leading to cerebral dysfunction.en_US
dc.language.isoen_USen_US
dc.publisherElsevier Taiwan LLCen_US
dc.subjectCOVID-19en_US
dc.subjectEncephalitisen_US
dc.subjectEncephalopathyen_US
dc.subjectOmicronen_US
dc.titleRisk factors of Omicron variant associated acute encephalitis/encephalopathy in childrenen_US
dc.typeArticleen_US
Appears in Collections:VOL 56 NO 6 2023

Files in This Item:
File Description SizeFormat 
1169-1177.pdf651.42 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.